Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 6.87K | 102.54K | 159.51K | 781.21K | 367.86K |
Gross Profit | 3.22K | 25.27K | 72.37K | 386.56K | 127.70K |
EBITDA | -2.73M | -1.98M | -2.45M | -1.97M | -1.67M |
Net Income | -2.85M | -2.16M | -2.86M | -2.69M | -1.91M |
Balance Sheet | |||||
Total Assets | 1.32M | 513.00K | 427.33K | 2.75M | 1.79M |
Cash, Cash Equivalents and Short-Term Investments | 498.30K | 73.07K | 248.14K | 2.01M | 1.15M |
Total Debt | 126.33K | 225.26K | 300.00K | 986.68K | 333.78K |
Total Liabilities | 983.58K | 622.40K | 700.75K | 1.17M | 579.78K |
Stockholders Equity | 374.94K | -109.41K | -273.41K | 1.58M | 1.21M |
Cash Flow | |||||
Free Cash Flow | -2.10M | -2.01M | -2.82M | -2.04M | -2.27M |
Operating Cash Flow | -2.10M | -2.01M | -2.82M | -2.04M | -2.25M |
Investing Cash Flow | -258.66K | 0.00 | 0.00 | 0.00 | -20.91K |
Financing Cash Flow | 2.53M | 1.83M | 142.12K | 2.91M | 1.22M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
64 Neutral | €51.98B | 3.81 | -30.25% | 2.12% | 6.83% | 73.58% | |
62 Neutral | AU$28.72M | ― | -228.61% | ― | -36.24% | -2.67% | |
56 Neutral | AU$50.22M | ― | -13.67% | ― | -18.79% | -28.57% | |
50 Neutral | AU$36.31M | ― | ― | 0.40% | 66.36% | ||
44 Neutral | AU$21.37M | ― | -24.21% | ― | -11.35% | -49.13% | |
35 Underperform | AU$42.36M | ― | -243.28% | ― | -32.45% | 33.72% | |
31 Underperform | AU$2.03M | ― | ― | ― | ― |
Nanoveu Limited announced a change of address for its registered office and principal place of business to Level 45, 108 St Georges Terrace, Perth, Western Australia, effective from 5 May 2025. This update reflects the company’s ongoing operational adjustments and signifies its commitment to maintaining its presence in the region, potentially impacting its business operations and stakeholder engagement.
Nanoveu Ltd. has announced a proposed issue of securities, including options and ordinary shares, set to be issued on May 9, 2025. This strategic move aims to strengthen the company’s financial position and support its ongoing growth initiatives, potentially impacting its market presence and offering opportunities for stakeholders.
Nanoveu Limited has successfully raised $2.3 million through a placement of shares to sophisticated and professional investors, with significant participation from its Chairman. The funds will be used to accelerate the development and commercialization of its key technologies, including the EMASS semiconductor platform, EyeFly3D™ visualization technology, and Nanoshield™ Solar coatings, positioning the company for global expansion and enhanced market presence.
Nanoveu Limited has announced its Annual General Meeting (AGM) scheduled for May 30, 2025, in Perth, Australia. Shareholders are encouraged to participate by submitting proxy forms ahead of the meeting, as the company will not use video conferencing technology. This move underscores Nanoveu’s commitment to maintaining traditional shareholder engagement methods while adapting to electronic communication for meeting materials, reflecting a balance between innovation and conventional practices.
Nanoveu Limited has requested a trading halt on its securities pending an announcement regarding a capital raising. This move, authorized by the Board of Directors, aims to provide the company with the necessary time to finalize details, potentially impacting its market positioning and stakeholder interests.
Nanoveu Limited has appointed Scott Smyser as Vice President of Sales and Marketing for its Semiconductor Technologies division, marking a significant step in its growth strategy. With over 25 years of experience in the semiconductor industry, Smyser’s leadership is expected to drive the commercialization and global expansion of Nanoveu’s semiconductor solutions, positioning the company for long-term growth in high-impact sectors such as IoT, AI, and smart energy systems.
Nanoveu Ltd. has announced a proposed issue of 7,500,000 performance rights securities, with an expected issue date of June 3, 2025. This strategic move is aimed at strengthening the company’s financial position and enhancing its market presence, potentially impacting its operations and stakeholder interests positively.
Nanoveu Ltd. has announced a change in the director’s interest notice, specifically concerning Alfred Chong. The change involves the expiry of 2,462,500 performance rights that did not meet their performance milestones, affecting Mr. Chong’s indirect and direct interests in the company’s securities. This adjustment reflects the company’s adherence to performance-based incentives and could impact stakeholders’ perception of management’s alignment with company goals.
Nanoveu Ltd. announced the cessation of 11,881,475 performance rights as the conditions for these securities were not met by the deadline of March 31, 2025. This development may impact the company’s capital structure and could have implications for stakeholders, reflecting on the company’s operational strategies and market positioning.
Nanoveu Limited has released its corporate governance statement for the financial year ending December 31, 2024. The statement, approved by the board and available on the company’s website, outlines the extent to which Nanoveu has adhered to the ASX Corporate Governance Council’s recommendations. This disclosure is crucial for stakeholders as it provides transparency on the company’s governance practices and compliance, potentially impacting investor confidence and the company’s market positioning.
Nanoveu Limited has released its annual financial report for the year ending December 31, 2024. The report includes comprehensive financial statements and disclosures, providing insights into the company’s financial performance and position. This release is significant as it offers stakeholders a detailed view of Nanoveu’s financial health and operational outcomes, which can influence investor decisions and market perceptions.
Nanoveu Limited has announced the vesting of 39,080,000 Performance Rights, which can now be converted into fully paid ordinary shares. This development is part of the company’s strategy to enhance its market position in the 3D content, AI, and edge computing markets, potentially impacting its operations and stakeholder interests positively.
Nanoveu Limited has announced the application for the quotation of 172,413,793 fully paid ordinary securities on the Australian Securities Exchange (ASX) as part of a previously announced transaction. This move is expected to enhance the company’s market presence and provide additional capital for its ongoing projects, potentially impacting its operational capabilities and stakeholder interests positively.
Nanoveu Limited has completed the acquisition of EMASS Semiconductor, enhancing its capabilities in AI-driven edge computing and semiconductor technology. This strategic move positions Nanoveu to expand its offerings in industrial IoT, AI analytics, and 3D displays, strengthening its market position and creating new opportunities for growth.
Nanoveu Limited has announced its participation in the Embedded World 2025 Conference & Exhibition in Nuremberg, Germany, highlighting its focus on AI-driven edge semiconductor solutions. This participation underscores Nanoveu’s strategic positioning in the 3D content, AI, and edge computing markets, potentially enhancing its industry influence and offering stakeholders insight into its growth trajectory.
Weebit Nano Ltd. and EMASS have announced a collaboration to demonstrate the integration of Weebit’s ReRAM technology with EMASS’s ultra-low-power AI SoC at the embedded world 2025. This partnership aims to enhance energy efficiency and performance in edge AI applications, addressing the growing demand for sustainable and high-performance edge computing solutions. The collaboration is expected to pave the way for a new generation of intelligent, energy-conscious computing devices, potentially impacting industries such as IoT, healthcare, automotive, and industrial automation.
Nanoveu Limited announced the settlement of its final tranche of a capital raising initiative, securing an additional $410,096 through the issuance of new shares and options. This financial maneuver aims to enhance the company’s capabilities in delivering innovative 3D content and antimicrobial solutions, potentially strengthening its market position and offering benefits to stakeholders through expanded technological capabilities.
Nanoveu Ltd. has announced the issuance of 15,772,923 unquoted securities, specifically options expiring on December 31, 2026, with an exercise price of $0.05. This issuance, which is part of a previously announced transaction, signifies a strategic move in the company’s financial operations, potentially impacting its liquidity and shareholder value.
Nanoveu Limited has executed a binding Share Sale Agreement for the acquisition of Embedded A.I. Systems Pte. Ltd., a specialist in System-on-Chip semiconductor design. This strategic acquisition is set to enhance Nanoveu’s product offerings and positions the company to capitalize on the growing demand for ultra-low power edge computing and AI applications. With the recent appointment of semiconductor veteran Mark Goranson to lead the new semiconductor division, Nanoveu aims to integrate EMASS’s technology into its EyeFly3D platform and pursue partnerships with manufacturers in the wearables, drones, and IoT sectors. This move aligns Nanoveu with other ASX-listed semiconductor innovators, strengthening its competitive position in a rapidly growing market.